ArticleThe Journal of clinical investigation2021

Inhibiting the MNK1/2-eIF4E axis impairs melanoma phenotype switching and potentiates antitumor immune responses.

Fan Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.